This page shows the latest ENSEMBLE news and features for those working in and with pharma, biotech and healthcare.
The phase 3 ENSEMBLE trial was launched in collaboration with the US Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) and the US National Institute ... In an interim analysis of results from
Last week, J&J announced that it would decrease the size of the ENSEMBLE trial after cases surged across the US. ... Interim results from the phase 1/2a ENSEMBLE trial demonstrated that the shot has a promising safety profile and immunogenicity after a
We continue to anticipate that interim data from the ENSEMBLE trial will be available by the end of January,” J&J said in a statement. ... Interim results from the phase 1/2a ENSEMBLE trial demonstrated that the shot has a promising safety profile and
In an interim analysis of results from the ENSEMBLE phase 1/2a trial, J&J’s vaccine demonstrated a promising safety profile and immunogenicity after a single dose. ... The pharma giant is initiating the phase 3 ENSEMBLE trial in collaboration with the
The ENSEMBLE 2 study will enrol participants in the UK, the US, France, Germany, Spain, Belgium, South Africa, Colombia and the Philippines. ... As part of this deal, the UK also agreed to co-fund the phase 3 ENSEMBLE 2 trial.
In a separate announcement, J&J said that the Independent Data Safety Monitoring Board (DSMB) overseeing the pause of its phase 3 ENSEMBLE study recommended resuming trial recruitment.
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
The ‘one-size-fits-all’ approach will not change behaviours.”. An ensemble performance. Naturally, patients are the focal point of behaviour change programmes.
While these guys may not sound as good together as the ensemble musical cast of Station to Station or “Heroes”, there's little doubt this approach represents a refreshing challenge to
230. Cipla Medpro / Cipla. Acquisition. Generics. 215. Ensemble Therapeutics / Boehringer Ingelheim.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...